Aurora Spine upsized its non-brokered private placement offering of common shares, due to investor demand.
Here are six things to know:
1. The company increased its private placement to up to 10 million common shares, at CDN$0.10 per common share for gross proceeds of up to $1 million.
2. The offering will close in early February.
3. Aurora Spine believes some company directors and officers may take part in the offering.
4. The company will use the offering's net proceeds for general working capital.
5. All issued securities with this offering will undergo a statutory four-month hold period.
6. Aurora Spine develops screwless, innovative, minimally invasive, regenerative spinal implant technologies.